0001412100false00014121002023-11-082023-11-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
November 8, 2023 (November 8, 2023)
MAIDEN HOLDINGS, LTD.
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | | | | |
| Bermuda | | 001-34042 | | 98-0570192 |
(State or other jurisdiction of incorporation) | |
(Commission File Number) | |
(IRS Employer Identification No.) |
94 Pitts Bay Road, Pembroke HM08, Bermuda
(Address of principal executive offices and zip code)
(441) 298-4900
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | | | | | | | | | | |
| | ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
| | |
| | ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
| | |
| | ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
| | |
| | ☒ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) | | |
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of Each Class | | Trading symbol(s) | | Name of Each Exchange on Which Registered |
| Common Shares, par value $0.01 per share | | MHLD | | NASDAQ Capital Market |
| | | | | |
| Item 2.02 | Results of Operations and Financial Condition. |
On November 8, 2023, the Company issued a press release announcing its results of operations for the three and nine months ended September 30, 2023. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.
The information contained in this Item 2.02 and in the accompanying exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section or incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
On November 8, 2023, the Company posted the Maiden Holdings, Ltd. Investor Update Presentation, November 2023 via its investor relations website at https://www.maiden.bm/investor_relations, which presentation is included as Exhibit 99.3 to this Current Report on Form 8-K.
The information under Item 7.01 and the Investor Presentation included to this Form 8-K as Exhibit 99.3 shall be deemed to be “furnished” and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act. The furnishing of the information in this report is not intended to, and does not, constitute a determination or admission by the Company that the information in this report is material or complete, or that investors should consider this information before making an investment decision with respect to any security of the Company.
On November 8, 2023, the Company issued a press release announcing its results of operations for the three and nine months ended September 30, 2023 via its investor relations website at https://www.maiden.bm/investor_relations, which press release is included as Exhibit 99.2 to this Current Report on Form 8-K and incorporated herein by reference.
| | | | | |
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibit
| | | | | | | | |
| Exhibit | | |
| No. | | Description |
| | | |
| 99.1 | | |
| 99.2 | | |
| 99.3 | | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | | | | | | | |
| Date: | November 8, 2023 | MAIDEN HOLDINGS, LTD. |
| | | | |
| | | By: | /s/ Lawrence F. Metz |
| | | | Lawrence F. Metz
Executive Vice Chairman and Group President |
| | | | |
EXHIBIT INDEX
| | | | | | | | |
| Exhibit | | |
| No. | | Description |
| | | |
| 99.1 | | |
| 99.2 | | |
| 99.3 | | |
Exhibit 99.1
PRESS RELEASE
Maiden Holdings, Ltd. Announces
Third Quarter 2023 Financial Results
PEMBROKE, Bermuda, November 8, 2023 - Maiden Holdings, Ltd. (NASDAQ: MHLD) ("Maiden" or the "Company") today reported its third quarter 2023 results. Maiden reported a net loss attributable to Maiden common shareholders of $3.5 million or $0.03 per diluted common share for the third quarter of 2023 compared to net loss available to Maiden common shareholders of $8.2 million or $0.09 per diluted common share in the third quarter of 2022.
Non-GAAP operating loss(5) was $11.7 million or $0.12 per diluted common share for the third quarter of 2023 compared to non-GAAP operating loss of $21.1 million or $0.24 per diluted common share for the same period in 2022.
Maiden's book value per common share(1) was $2.60 at September 30, 2023 compared to $2.80 at December 31, 2022. Adjusted for the unamortized deferred gain on ceded retroactive reinsurance of $56.5 million at September 30, 2023, the Company's adjusted book value per common share(2) was $3.16 at September 30, 2023.
Patrick J. Haveron, Maiden’s Chief Executive Officer commented on the third quarter of 2023 financial results: “Continued increases in our investment results were offset by a higher underwriting loss during the third quarter, primarily due to adverse loss development in both of our segments."
Mr. Haveron added, “The continued improvement in our investment performance was principally the result of significantly higher investment income as our floating rate and adjustable-rate securities responded to the continuing rise in interest rates, with limited impact on asset values. Net investment income increased by $2.4 million or 36.3% compared to last year's third quarter, and with 37.8% of our fixed income investments now in floating rate securities, our results could benefit further if additional increases in interest rates occur. Our alternative asset portfolio continues to make contributions as we recognized income on several of our equity method investments during the quarter as well."
"The rise in interest rates and subsequent economic and financial markets uncertainty continues to lead to a more measured pace of deployment of new alternative investment opportunities, and we are adjusting our investment focus accordingly, by seeking income producing, lower risk assets at more attractive yields. Against this market backdrop, particularly as regards to timing of monetizing certain investments, we believe our alternative investment portfolio remains well positioned to achieve its targeted longer-term returns.”
“During the third quarter, we continued our long-term capital management strategy and repurchased 520,475 common shares. We expect to continue a disciplined and prudent approach to share repurchases as part of this program.”
“Our underwriting loss in the third quarter was primarily the result of adverse development in our AmTrust segment. During the third quarter, Hospital Liability experienced adverse loss development of $6.0 million as losses prior to 2016 emerged, which is not covered by the LPT/ADC reinsurance we have in place. In addition, more modest adverse development in other lines occurred, principally Auto Liability and Specialty programs. We continue to respond to the emergence of this additional loss data as it is reported. Loss development in our Diversified segment was again primarily from a German auto program in run-off from our IIS unit along with smaller development from a variety of older treaty programs.”
“Finally, our consolidated balance sheet at September 30, 2023 does not reflect $1.20 in net U.S. deferred tax assets which still maintains a full valuation allowance. While the ongoing adverse reserve development experienced may impact the timing related to ultimately recognizing this asset, we believe the factors that will enable us to ultimately recognize these tax assets in the future continues to accumulate, particularly with our asset portfolio producing more current income.”
Mr. Haveron concluded, "We continue to actively evaluate our strategies as we look to build a more consistent base of revenue and profits while leveraging our experience in insurance and reinsurance markets, including distribution channels."
Consolidated Results for the Quarter Ended September 30, 2023
Net loss attributable to Maiden common shareholders for the three months ended September 30, 2023 was $3.5 million, compared to a net loss attributable to Maiden common shareholders of $8.2 million for the same respective period in 2022 largely due to the following:
•lower underwriting loss(4) which was $10.9 million in the third quarter of 2023 compared to an underwriting loss of $12.6 million in the same period in 2022 which was influenced by:
•adverse prior year loss development of $7.8 million in the third quarter of 2023 compared to adverse prior year loss development of $0.8 million during the same period in 2022; and
•on a current accident year basis, underwriting loss of $3.1 million for the three months ended September 30, 2023 compared to an underwriting loss of $11.8 million for the same period in 2022.
•higher total income from investment activities of $11.5 million for the three months ended September 30, 2023 compared to $4.7 million for the same period in 2022 which was comprised of:
•net investment income of $9.0 million for the three months ended September 30, 2023 compared to $6.6 million for the same period in 2022;
•net realized and unrealized investment gains of $0.2 million for the three months ended September 30, 2023 compared to net realized and unrealized investment losses of $1.6 million for the same period in 2022; and
•interest in income of equity method investments of $2.2 million for the three months ended September 30, 2023 compared to a loss of $0.4 million for the same period in 2022.
•corporate general and administrative expenses decreased to $3.9 million for the three months ended September 30, 2023 compared to $4.1 million for the same period in 2022.
•foreign exchange and other gains of $4.6 million during the three months ended September 30, 2023, compared to foreign exchange and other gains of $8.6 million for the same period in 2022.
Net premiums written for the three months ended September 30, 2023 were $8.6 million compared to $5.2 million for the same period in 2022 due to lower negative cession adjustments in the third quarter of 2023 for the AmTrust Reinsurance segment. Net written premiums in the AmTrust Reinsurance segment were $1.9 million in the three months ended September 30, 2023 compared to negative premiums of $0.8 million for the same period in 2022. Net premiums written in the Diversified Reinsurance segment increased by $0.7 million for the three months ended September 30, 2023 compared to the same period in 2022 due to growth in direct premiums for Credit Life programs written by wholly owned Swedish subsidiaries Maiden Life Försäkrings AB ("Maiden LF") and Maiden General Försäkrings AB ("Maiden GF"). Net premiums earned increased by $0.2 million for the three months ended September 30, 2023 compared to the same period in 2022.
Net investment income increased by $2.4 million or 36.3% for the three months ended September 30, 2023 compared to the same period in 2022, primarily due to higher annualized average book yields from fixed income assets which increased to 4.3% for the three months ended September 30, 2023 compared to 2.2% for the same period in 2022. Our fixed income assets include available-for-sale ("AFS") securities, cash and restricted cash, funds withheld receivable, and loan to related party. These amounts are an average of the amounts disclosed in our quarterly U.S. GAAP consolidated financial statements.
Annualized yields on fixed income assets increased partly due to 37.8% of our fixed income investments as of September 30, 2023 invested in floating rate assets which enabled us to take advantage of a higher interest rate environment by reinvesting at higher yields more quickly. Also, interest income on funds withheld and related party loans have increased since these assets carry periodically adjusted interest rates and have directly benefited from the recent rise in interest rates. Average aggregate fixed income assets decreased by 40.6% due to the continued run-off of our reinsurance liabilities previously written on prospective risks, resulting in significant negative operating cash flows as we run-off our existing reinsurance liabilities primarily through the funds withheld receivable.
Net realized and unrealized investment gains for the three months ended September 30, 2023 were $0.2 million compared to net losses of $1.6 million for the same period in 2022, which included net unrealized investment gains on alternative investments of $0.5 million for the third quarter of 2023 compared to net unrealized losses of $1.7 million for the third quarter of 2022.
Net loss and LAE decreased by $2.3 million during the three months ended September 30, 2023 compared to the same period in 2022. Net loss and LAE for the third quarter of 2023 was impacted by net adverse prior year reserve development of $7.8 million compared to net adverse prior year reserve development of $0.8 million during the third quarter of 2022. The AmTrust Reinsurance segment had adverse prior year loss development of $6.0 million in the third quarter of 2023 due to European Hospital Liability compared to adverse development of $1.4 million for the third quarter of 2022. The Diversified Reinsurance segment had adverse prior year loss development of $1.9 million in the third quarter of 2023, compared to favorable prior year
development of $0.6 million for the third quarter of 2022, mostly due to development in other runoff business lines.
Commission and other acquisition expenses were $5.3 million for the three months ended September 30, 2023 compared to $5.4 million for the same period in 2022. Total general and administrative expenses increased by $0.3 million, or 4.6% for the three months ended September 30, 2023, compared to the same respective period in 2022.
Consolidated Results for the nine months ended September 30, 2023
Net loss attributable to Maiden common shareholders for the nine months ended September 30, 2023 was $17.8 million compared to net income available to Maiden common shareholders of $19.2 million for the same period in 2022. The net income for the nine months ended September 30, 2022 included $28.2 million of gains from the repurchase of our preference shares. Excluding the gain on the repurchase of our preference shares in 2022, our net loss for the nine months ended September 30, 2023 was $17.8 million compared to a net loss of $9.0 million for the same period in 2022. The net decrease in results for the nine months ended September 30, 2023 compared to 2022 was primarily due to:
•a higher underwriting loss of $28.4 million for the nine months ended September 30, 2023 compared to underwriting loss of $19.4 million for the same period in 2022 largely due to:
•adverse prior year loss development of $16.0 million for the nine months ended September 30, 2023 compared to favorable prior year development of $5.5 million for the same period in 2022 primarily related to the quota share reinsurance agreements in the AmTrust Reinsurance segment;
•on a current accident year basis, an underwriting loss of $12.4 million for the nine months ended September 30, 2023 compared to an underwriting loss of $24.9 million for the same period in 2022, primarily due to results within the AmTrust Reinsurance segment as discussed below; and
•significantly higher than expected negative premium adjustments in the AmTrust Reinsurance segment related to adjustments for estimated surcharges on Workers' Compensation policies and inuring AmTrust reinsurance for certain programs in Specialty Risk and Extended Warranty cessions (collectively the "AmTrust Cession Adjustments"), net of commission and loss adjustments, contributed an underwriting loss of $5.1 million to our reported results for the nine months ended September 30, 2022.
•foreign exchange and other losses of $0.8 million for the nine months ended September 30, 2023 compared to foreign exchange and other gains of $19.1 million for the same period in 2022.
The decrease in our year-to-date results were partly offset by the following favorable factors:
•higher total income from investment activities of $38.4 million for the nine months ended September 30, 2023 compared to $21.6 million for the same period in 2022 which was comprised of:
•net investment income increased to $29.1 million for the nine months ended September 30, 2023 compared to $20.9 million for the same period in 2022;
•realized and unrealized investment gains were $2.4 million for the nine months ended September 30, 2023 compared to realized and unrealized gains of $2.8 million for the same period in 2022; and
•interest in income of equity method investments was $6.9 million for the nine months ended September 30, 2023 compared to a loss of $2.1 million for the same period in 2022.
•corporate general and administrative expenses decreased to $13.8 million for the nine months ended September 30, 2023 compared to $15.4 million for the same period in 2022 largely due to lower stock-based incentive compensation costs which were $1.4 million compared to $2.5 million for the same period in 2022.
Net premiums written for the nine months ended September 30, 2023 were $16.3 million compared to $(1.9) million for the same period in 2022 largely due to significant negative written premiums for the AmTrust Cession Adjustments during the nine months ended September 30, 2022. Net written premiums in the AmTrust Reinsurance segment were $(3.9) million in the nine months ended September 30, 2023 compared to net premiums of $(18.5) million for the same period in 2022. For the nine months ended September 30, 2023, the negative gross and net premiums written include AmTrust Cession Adjustments of $6.1 million due to the cancellation of cases in a certain program within Specialty Risk and Extended Warranty. Negative premiums written in the nine months ended September 30, 2022 reflect AmTrust Cession Adjustments of $15.8 million related to the following items:
•$11.0 million of premium reductions on Workers Compensation policy surcharges in Small Commercial Business subsequent to the termination of the AmTrust Quota Share; and
•$4.8 million of premium reductions to AmTrust's inuring reinsurance for certain programs in Specialty Risk and Extended Warranty which reduced the amount of premium ceded to Maiden.
Net premiums written in the Diversified Reinsurance segment increased by $3.5 million for the nine months ended September 30, 2023 compared to the same period in 2022 due to growth in direct premiums for Credit Life programs written by Maiden LF and Maiden GF.
Net premiums earned increased by $8.7 million for the nine months ended September 30, 2023 compared to the same period in 2022 largely due to significant negative earned premium adjustments made in the AmTrust Reinsurance segment during the first quarter of 2022 as well as growth in Credit Life programs written by Maiden LF and Maiden GF in our Diversified Reinsurance segment.
Net investment income increased by $8.2 million or 39.5% for the nine months ended September 30, 2023 compared to the same period in 2022, primarily due to higher annualized average book yields from fixed income assets which increased to 4.1% for the nine months ended September 30, 2023 compared to 2.0% for the same period in 2022. The increase in annualized book yields was driven by higher crediting interest rates on our funds withheld with AmTrust which increased to 3.5% in 2023 compared to 2.1% in 2022, and a higher weighted average interest rate on our related party loan which increased to 6.9% during the nine months ended September 30, 2023, compared to 3.0% for the same period in 2022.
Net realized and unrealized investment gains for the nine months ended September 30, 2023 were $2.4 million compared to gains of $2.8 million for the same period in 2022. This included net realized and unrealized investment gains on alternative investments of $3.5 million for the nine months ended September 30, 2023 compared to net realized and unrealized gains of $1.7 million for the same period in 2022.
Net loss and LAE increased by $14.5 million during the nine months ended September 30, 2023 compared to the same period in 2022. Net losses were impacted by net adverse prior year loss development of $16.0 million for the nine months ended September 30, 2023 compared to favorable prior year reserve development of $5.5 million for the same period in 2022. The AmTrust Reinsurance segment had adverse prior year loss development of $12.0 million for the nine months ended September 30, 2023 compared to favorable development of $3.5 million for the same period in 2022. The Diversified Reinsurance segment had adverse prior year loss development of $3.9 million for the nine months ended September 30, 2023, compared to favorable development of $2.0 million for the same period in 2022, mostly due to recent development in other runoff business lines and included the recognition of expected credit losses on reinsurance recoverable on unpaid losses.
Commission and other acquisition expenses increased by $1.7 million or 13.3% for the nine months ended September 30, 2023, compared to the same period in 2022 driven by significantly higher AmTrust Cession Adjustments made in 2022, which resulted in a corresponding decrease in commission costs and brokerage fees in 2022.
Total general and administrative expenses decreased by $0.9 million or 3.8% for the nine months ended September 30, 2023, compared to the same period in 2022 primarily due to lower stock-based incentive compensation costs as discussed above.
Operating Results for the three and nine months ended September 30, 2023
In addition to other adjustments, management adjusts reported GAAP net (loss) income and underwriting results by excluding incurred losses and LAE covered by the Loss Portfolio Transfer and Adverse Development Cover Agreement ("LPT/ADC Agreement") with Cavello Bay Reinsurance Ltd. ("Cavello"), a subsidiary of Enstar Group Limited. Such losses are fully recoverable from Cavello, and therefore adjusting for these losses shows the ultimate economic benefit of the LPT/ADC Agreement to Maiden.
Non-GAAP operating loss was $11.7 million or $0.12 per diluted common share for the third quarter of 2023 compared to non-GAAP operating loss of $21.1 million or $0.24 per diluted common share for the third quarter of 2022. Adjusted to include net realized and unrealized investment gains and losses as well as an interest in income or loss of equity method investments which are recurring parts of investment results with the Company’s underwriting activities in run-off, the non-GAAP operating loss were $9.3 million or $0.09 per diluted common share for the third quarter of 2023, compared to non-GAAP operating loss of $23.0 million or $0.26 per diluted common share for the third quarter of 2022.
Non-GAAP operating loss was $15.2 million or $0.15 per diluted common share for the nine months ended September 30, 2023, compared to non-GAAP operating loss of $11.4 million or $0.13 per diluted common share for the same period in 2022. Adjusted to include net realized and unrealized investment gains and an interest in income or loss of equity method investments which are recurring parts of investment results with the Company’s underwriting activities in run-off, the non-GAAP operating loss was $5.8 million or $0.06 per diluted common share for the nine months ended September 30, 2023, compared to non-GAAP operating loss of $10.7 million or $0.12 per diluted common share for the same period in 2022.
Similar to the reported GAAP results, the reduction in non-GAAP operating results for the nine months ended September 30, 2023 compared to the same respective period in 2022 primarily reflect gains from the repurchase of preference shares of $28.2 million that were recognized in the nine months ended September 30, 2022.
The unamortized deferred gain on retroactive reinsurance under the LPT/ADC Agreement with Cavello was $56.5 million as of September 30, 2023, an increase of $11.1 million compared to $45.4 million at December 31, 2022. Adjusted for a decrease in the deferred gain under the LPT/ADC Agreement of $1.2 million and an increase of $11.1 million during the three and nine months ended September 30, 2023, respectively, the non-GAAP underwriting loss(9) was $12.1 million and $17.3 million, respectively. This compared to a non-GAAP underwriting loss of $18.9 million and $30.1 million when adjusted for the decrease in the deferred gain under the LPT/ADC Agreement of $6.3 million and $10.7 million during the three and nine months ended September 30, 2022, respectively.
The non-GAAP underwriting results in both respective periods included loss development in the AmTrust Reinsurance segment not covered by the LPT/ADC Agreement, specifically the run-off of the AmTrust Quota Share with losses occurring after December 31, 2018, as well as adverse loss development under the European Hospital Liability Quota Share. Also, the results included an underwriting loss in the Diversified Reinsurance segment of $2.5 million and $7.6 million for the three and nine months ended September 30, 2023, respectively, compared to underwriting income of $40.0 thousand and $0.3 million for the same respective periods in 2022.
Please refer to the Non-GAAP Financial Measures tables in this earnings release for additional information on these non-GAAP financial measures and reconciliation of these measures to the appropriate GAAP measures.
Quarterly Report on Form 10-Q for the Period Ended September 30, 2023 and Other Financial Matters
The Company’s Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2023 was filed with the U.S. Securities and Exchange Commission on November 8, 2023. Additional information on the matters reported in this news release along with other required disclosures can be found in that filing.
Total assets were $1.6 billion at September 30, 2023 and decreased by $269.4 million compared to December 31, 2022. Shareholders' equity was $263.2 million at September 30, 2023 compared to $284.6 million at December 31, 2022.
Adjusted shareholders' equity(2) was $319.8 million at September 30, 2023 compared to $330.0 million at December 31, 2022, which includes an unamortized deferred gain under the LPT/ADC Agreement of $56.5 million at September 30, 2023 and $45.4 million at December 31, 2022.
During the three and nine months ended September 30, 2023, Maiden Reinsurance repurchased 520,475 and 820,105 common shares, respectively, at an average price per share of $1.86 and $1.93, respectively, pursuant to the Company's $100.0 million share repurchase authorization, which was approved by the Company's Board of Directors on February 21, 2017. The Company had $72.7 million remaining for authorized common share repurchases at September 30, 2023. Subsequent to September 30, 2023 and through the period ended November 7, 2023, Maiden Reinsurance repurchased 226,250 additional common shares at an average price per share of $1.67 under the Company's authorized common share repurchase plan. The Company's remaining share repurchase authorization was $72.3 million at November 7, 2023.
On May 3, 2023, the Company's Board of Directors approved the repurchase, including the repurchase by Maiden Reinsurance in accordance with its investment guidelines, of up to $100.0 million of the Company's Senior Notes from time to time at market prices in open market purchases or as may be privately negotiated. During the nine months ended September 30, 2023, the Company repurchased 5,567 notes of the 2013 Senior Notes at an average price per unit of $17.10 and a gain of $39.9 thousand was realized. The Company's current remaining authorization is $99.9 million for Senior Notes repurchases.
As of September 30, 2023, GLS and its subsidiaries have insurance related liabilities of $26.2 million including mainly total reserves of $19.9 million, an underwriting-related derivative liability of $4.0 million, and net deferred gains on retroactive reinsurance of $2.3 million.
The Company's wholly owned subsidiary, Maiden Holdings North America, Ltd., holds net operating loss carryforwards ("NOLs") which were $304.9 million as of September 30, 2023. These NOLs, in combination with additional net deferred tax assets primarily related to our insurance liabilities, result in a net U.S. deferred tax asset (before valuation allowance) of $121.0 million or $1.20 per common share as of September 30, 2023. The net deferred tax assets are not presently recognized on the Company’s balance sheet as a full valuation allowance is carried against them.
The Company no longer presents certain non-GAAP measures such as combined ratio and its related components in its news release or quarterly reports, as it believes that as the run-off of its reinsurance portfolios progresses, such ratios are increasingly not meaningful and of less value to readers as they evaluate our financial results.
Quarterly Dividends
The Company's Board of Directors did not authorize any quarterly dividends on its common shares during the three and nine months ended September 30, 2023 and 2022.
About Maiden Holdings, Ltd.
Maiden Holdings, Ltd. is a Bermuda-based holding company formed in 2007. Maiden creates shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. Maiden also provides a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core to those companies' operations, working with clients to develop and implement finality solutions including acquiring entire companies that enable our clients to meet their capital and risk management objectives.
(1)(2)(4)(5)(9) Please refer to the Non-GAAP Financial Measures tables for additional information on these non-GAAP financial measures and reconciliation of these measures to GAAP measures.
Special Note about Forward Looking Statements
Certain statements in this press release, other than purely historical information, including estimates, projections, statements relating to the Company’s business plans, objectives and expected operating results and the assumptions upon which those statements are based are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include general statements both with respect to the Company and the insurance industry and generally are identified with the words "anticipate", "believe", "expect", "predict", "estimate", "intend", "plan", "project", "seek", "potential", "possible", "could", "might", "may", "should", "will", "would", "will be", "will continue", "will likely result" and similar expressions. In light of the risks and uncertainties inherent in all forward-looking statements, the inclusion of such statements in this press release should not be considered as a representation by the Company or any other person that the Company’s objectives or plans or other matters described in any forward-looking statement will be achieved. These statements are based on current plans, estimates, assumptions and expectations. Actual results may differ materially from those projected in such forward-looking statements and therefore, you should not place undue reliance on them. Important factors that could cause actual results to differ materially from those in such forward-looking statements are set forth in Item 1A "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. COVID-19 triggered a period of increased volatility with respect to global economic conditions. During the year ended December 31, 2022, inflation became unusually high in many parts of the world, and central banks in the U.S. and other countries aggressively raised interest rates to counter inflation by slowing economic activity. Monetary policy tightening actions are ongoing at December 31, 2022, and their long-term impact on financial markets and the real economy is currently uncertain. Please also see additional risks described in "Part I, Item 1A, Risk Factors" of our Annual Report on Form 10-K for the year ended December 31, 2022.
The Company cautions that the list of important risk factors in its Annual Report on Form 10-K for the year ended December 31, 2022 is not intended to be and is not exhaustive. The Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law, and all subsequent written and oral forward-looking statements attributable to the Company or individuals acting on the Company’s behalf are expressly qualified in their entirety by this paragraph. If one or more risks or uncertainties materialize, or if the Company’s underlying assumptions prove to be incorrect, the Company’s actual results may vary materially from what was projected. Any forward-looking statements in this press release reflect the Company’s current view with respect to future events and are subject to these and other risks, uncertainties and assumptions relating to the Company’s operations, results of operations, growth, strategy and liquidity. Readers are cautioned not to place undue reliance on the forward-looking statements which speak only as of the dates of the documents in which such statements were made.
Any discrepancies between the amounts included in the results of operations discussion and the consolidated financial statement tables are due to rounding.
CONTACT:
FGS Global
Maiden@fgsglobal.com
MAIDEN HOLDINGS, LTD.
CONSOLIDATED BALANCE SHEETS
(In thousands of U.S. dollars, except share and per share data)
| | | | | | | | | | | | | | |
| | September 30,
2023 | | December 31, 2022 |
| | (Unaudited) | | (Audited) |
| ASSETS |
| Investments: | | | | |
Fixed maturities, available-for-sale, at fair value (amortized cost 2023 - $270,900; 2022 - $330,439) | | $ | 258,106 | | | $ | 314,527 | |
| Equity securities, at fair value | | 45,647 | | | 43,621 | |
| Equity method investments | | 79,400 | | | 80,159 | |
| Other investments | | 166,222 | | | 148,753 | |
| Total investments | | 549,375 | | | 587,060 | |
| Cash and cash equivalents | | 17,930 | | | 30,986 | |
| Restricted cash and cash equivalents | | 11,600 | | | 15,638 | |
| Accrued investment income | | 5,486 | | | 4,122 | |
| Reinsurance balances receivable, net | | 10,416 | | | 10,707 | |
| Reinsurance recoverable on unpaid losses | | 558,777 | | | 556,116 | |
| Loan to related party | | 167,975 | | | 167,975 | |
| Deferred commission and other acquisition expenses, net | | 19,122 | | | 24,976 | |
| Funds withheld receivable | | 229,568 | | | 441,412 | |
| Other assets | | 7,214 | | | 7,874 | |
| | | | |
| Total assets | | $ | 1,577,463 | | | $ | 1,846,866 | |
| LIABILITIES |
| Reserve for loss and loss adjustment expenses | | $ | 911,475 | | | $ | 1,131,408 | |
| Unearned premiums | | 50,691 | | | 67,081 | |
| Deferred gain on retroactive reinsurance | | 58,837 | | | 47,708 | |
| | | | |
| Accrued expenses and other liabilities | | 38,664 | | | 60,518 | |
| Senior notes - principal amount | | 262,361 | | | 262,500 | |
| Less: unamortized debt issuance costs | | 7,802 | | | 6,928 | |
| Senior notes, net | | 254,559 | | | 255,572 | |
| | | | |
| Total liabilities | | 1,314,226 | | | 1,562,287 | |
| Commitments and Contingencies | | | | |
| EQUITY |
| | | | |
| Common shares | | 1,497 | | | 1,492 | |
| Additional paid-in capital | | 885,748 | | | 884,259 | |
| Accumulated other comprehensive loss | | (38,893) | | | (41,234) | |
| Accumulated deficit | | (466,164) | | | (442,863) | |
| Treasury shares, at cost | | (118,951) | | | (117,075) | |
| | | | |
| | | | |
| Total Equity | | 263,237 | | | 284,579 | |
| Total Liabilities and Equity | | $ | 1,577,463 | | | $ | 1,846,866 | |
| | | | |
Book value per common share(1) | | $ | 2.60 | | | $ | 2.80 | |
| | | | |
| Common shares outstanding | | 101,085,340 | | | 101,532,151 | |
MAIDEN HOLDINGS, LTD.
CONSOLIDATED STATEMENTS OF INCOME (Unaudited)
(In thousands of U.S. dollars, except share and per share data)
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, |
| | 2023 | | 2022 | | 2023 | | 2022 |
| Revenues: | | | | | | | | |
| Gross premiums written | | $ | 8,660 | | | $ | 5,380 | | | $ | 16,371 | | | $ | (1,451) | |
| Net premiums written | | $ | 8,625 | | | $ | 5,222 | | | $ | 16,260 | | | $ | (1,915) | |
| Change in unearned premiums | | 3,854 | | | 7,029 | | | 16,260 | | | 25,731 | |
| Net premiums earned | | 12,479 | | | 12,251 | | | 32,520 | | | 23,816 | |
| Other insurance (expense) revenue, net | | (16) | | | 368 | | | 3 | | | 888 | |
| Net investment income | | 9,048 | | | 6,637 | | | 29,111 | | | 20,871 | |
| Net realized and unrealized investment gains (losses) | | 244 | | | (1,572) | | | 2,394 | | | 2,848 | |
| | | | | | | | |
| Total revenues | | 21,755 | | | 17,684 | | | 64,028 | | | 48,423 | |
| Expenses: | | | | | | | | |
| Net loss and loss adjustment expenses | | 15,156 | | | 17,426 | | | 36,503 | | | 22,017 | |
| Commission and other acquisition expenses | | 5,340 | | | 5,398 | | | 14,520 | | | 12,811 | |
| General and administrative expenses | | 6,787 | | | 6,491 | | | 23,734 | | | 24,671 | |
| Total expenses | | 27,283 | | | 29,315 | | | 74,757 | | | 59,499 | |
| Other expenses | | | | | | | | |
| Interest and amortization expenses | | 4,814 | | | 4,833 | | | 13,411 | | | 14,498 | |
| | | | | | | | |
| | | | | | | | |
| Foreign exchange and other (gains) losses | | (4,594) | | | (8,586) | | | 843 | | | (19,121) | |
| Total other expenses | | 220 | | | (3,753) | | | 14,254 | | | (4,623) | |
| Loss before income taxes | | (5,748) | | | (7,878) | | | (24,983) | | | (6,453) | |
| Less: Income tax (benefit) expense | | (31) | | | (91) | | | (253) | | | 451 | |
| Interest in income (loss) of equity method investments | | 2,190 | | | (373) | | | 6,942 | | | (2,143) | |
| | | | | | | | |
| | | | | | | | |
| Net loss | | (3,527) | | | (8,160) | | | (17,788) | | | (9,047) | |
| Gain from repurchase of preference shares | | — | | | — | | | — | | | 28,233 | |
| Net (loss) income (attributable) available to Maiden common shareholders | | $ | (3,527) | | | $ | (8,160) | | | $ | (17,788) | | | $ | 19,186 | |
| | | | | | | | |
| | | | | | | | |
| Basic and diluted (loss) earnings per share (attributable) available to Maiden common shareholders | | $ | (0.03) | | | $ | (0.09) | | | $ | (0.18) | | | $ | 0.22 | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| Annualized return on average common equity | | (5.3) | % | | (14.8) | % | | (8.7) | % | | 11.9 | % |
| Weighted average number of common shares - basic | | 101,454,767 | | 87,161,499 | | 101,586,759 | | 86,935,823 |
| Adjusted weighted average number of common shares and assumed conversions - diluted | | 101,454,767 | | 87,161,499 | | 101,586,759 | | 86,937,552 |
MAIDEN HOLDINGS, LTD.
SUPPLEMENTAL FINANCIAL DATA - SEGMENT INFORMATION (Unaudited)
(in thousands of U.S. dollars)
| | | | | | | | | | | | | | | | | | | | | | |
| For the Three Months Ended September 30, 2023 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 6,762 | | | $ | 1,898 | | | | | $ | 8,660 | |
Net premiums written | | $ | 6,727 | | | $ | 1,898 | | | | | $ | 8,625 | |
Net premiums earned | | $ | 7,207 | | | $ | 5,272 | | | | | $ | 12,479 | |
| Other insurance expense | | (16) | | | — | | | | | (16) | |
Net loss and loss adjustment expenses ("loss and LAE") | | (4,142) | | | (11,014) | | | | | (15,156) | |
Commission and other acquisition expenses | | (3,374) | | | (1,966) | | | | | (5,340) | |
General and administrative expenses(3) | | (2,216) | | | (661) | | | | | (2,877) | |
Underwriting loss (4) | | $ | (2,541) | | | $ | (8,369) | | | | | (10,910) | |
| Reconciliation to net loss | | | | | | | | |
| Net investment income and net realized and unrealized investment gains | | | | | | | | 9,292 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (4,814) | |
| | | | | | | | |
| | | | | | | | |
| Foreign exchange and other losses, net | | | | | | | | 4,594 | |
Other general and administrative expenses(3) | | | | | | | | (3,910) | |
| Income tax benefit | | | | | | | | 31 | |
| Interest in income of equity method investments | | | | | | | | 2,190 | |
| Net loss | | | | | | | | $ | (3,527) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| For the Three Months Ended September 30, 2022 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 6,185 | | | $ | (805) | | | | | $ | 5,380 | |
Net premiums written | | $ | 6,027 | | | $ | (805) | | | | | $ | 5,222 | |
Net premiums earned | | $ | 6,932 | | | $ | 5,319 | | | | | $ | 12,251 | |
| Other insurance revenue | | 368 | | | — | | | | | 368 | |
Net loss and LAE | | (1,965) | | | (15,461) | | | | | (17,426) | |
Commission and other acquisition expenses | | (3,394) | | | (2,004) | | | | | (5,398) | |
General and administrative expenses(3) | | (1,901) | | | (521) | | | | | (2,422) | |
Underwriting income (loss)(4) | | $ | 40 | | | $ | (12,667) | | | | | (12,627) | |
| Reconciliation to net loss | | | | | | | | |
| Net investment income and net realized and unrealized investment losses | | | | | | | | 5,065 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (4,833) | |
| | | | | | | | |
| | | | | | | | |
| Foreign exchange and other gains, net | | | | | | | | 8,586 | |
Other general and administrative expenses(3) | | | | | | | | (4,069) | |
| Income tax benefit | | | | | | | | 91 | |
| Interest in loss of equity method investments | | | | | | | | (373) | |
| Net loss | | | | | | | | $ | (8,160) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
MAIDEN HOLDINGS, LTD.
SUPPLEMENTAL FINANCIAL DATA - SEGMENT INFORMATION (Unaudited)
(in thousands of U.S. dollars)
| | | | | | | | | | | | | | | | | | | | | | |
| For the Nine Months Ended September 30, 2023 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 20,263 | | | $ | (3,892) | | | | | $ | 16,371 | |
Net premiums written | | $ | 20,152 | | | $ | (3,892) | | | | | $ | 16,260 | |
Net premiums earned | | $ | 21,882 | | | $ | 10,638 | | | | | $ | 32,520 | |
| Other insurance revenue | | 3 | | | — | | | | | 3 | |
Net loss and LAE | | (11,126) | | | (25,377) | | | | | (36,503) | |
Commission and other acquisition expenses | | (10,544) | | | (3,976) | | | | | (14,520) | |
General and administrative expenses | | (7,863) | | | (2,062) | | | | | (9,925) | |
| Underwriting loss | | $ | (7,648) | | | $ | (20,777) | | | | | (28,425) | |
| Reconciliation to net loss | | | | | | | | |
| Net investment income and net realized and unrealized investment gains | | | | | | | | 31,505 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (13,411) | |
| | | | | | | | |
| | | | | | | | |
| Foreign exchange and other losses, net | | | | | | | | (843) | |
Other general and administrative expenses | | | | | | | | (13,809) | |
| Income tax benefit | | | | | | | | 253 | |
| Interest in income from equity method investments | | | | | | | | 6,942 | |
| Net loss | | | | | | | | $ | (17,788) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
| For the Nine Months Ended September 30, 2022 | | Diversified Reinsurance | | AmTrust Reinsurance | | | | Total |
Gross premiums written | | $ | 17,069 | | | $ | (18,520) | | | | | $ | (1,451) | |
Net premiums written | | $ | 16,605 | | | $ | (18,520) | | | | | $ | (1,915) | |
Net premiums earned | | $ | 20,012 | | | $ | 3,804 | | | | | $ | 23,816 | |
| Other insurance revenue | | 888 | | | — | | | | | 888 | |
Net loss and LAE | | (2,945) | | | (19,072) | | | | | (22,017) | |
Commission and other acquisition expenses | | (10,684) | | | (2,127) | | | | | (12,811) | |
General and administrative expenses | | (7,007) | | | (2,281) | | | | | (9,288) | |
| Underwriting income (loss) | | $ | 264 | | | $ | (19,676) | | | | | (19,412) | |
| Reconciliation to net loss | | | | | | | | |
| Net investment income and net realized and unrealized investment gains | | | | | | | | 23,719 | |
| | | | | | | | |
Interest and amortization expenses | | | | | | | | (14,498) | |
| | | | | | | | |
| | | | | | | | |
| Foreign exchange and other gains, net | | | | | | | | 19,121 | |
Other general and administrative expenses | | | | | | | | (15,383) | |
| Income tax expense | | | | | | | | (451) | |
| Interest in loss from equity method investments | | | | | | | | (2,143) | |
| Net loss | | | | | | | | $ | (9,047) | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
| | | | | | | | |
MAIDEN HOLDINGS, LTD.
NON-GAAP FINANCIAL MEASURES (Unaudited)
(In thousands of U.S. dollars, except share and per share data)
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, |
| | 2023 | | 2022 | | 2023 | | 2022 |
Non-GAAP operating loss (5) | | $ | (11,747) | | | $ | (21,060) | | | $ | (15,173) | | | $ | (11,362) | |
Non-GAAP basic and diluted operating loss per common share attributable to Maiden common shareholders(5) | | $ | (0.12) | | | $ | (0.24) | | | $ | (0.15) | | | $ | (0.13) | |
| | | | | | | | |
Annualized non-GAAP operating return on average adjusted common equity(6) | | (14.4) | % | | (32.6) | % | | (6.2) | % | | (5.9) | % |
| Reconciliation of net (loss) income (attributable) available to Maiden common shareholders to non-GAAP operating loss: | | | | | | | | |
| Net (loss) income (attributable) available to Maiden common shareholders | | $ | (3,527) | | | $ | (8,160) | | | $ | (17,788) | | | $ | 19,186 | |
| Add (subtract): | | | | | | | | |
| Net realized and unrealized investment (gains) losses | | (244) | | | 1,572 | | | (2,394) | | | (2,848) | |
| | | | | | | | |
| Foreign exchange and other (gains) losses | | (4,594) | | | (8,586) | | | 843 | | | (19,121) | |
| Interest in (income) loss of equity method investments | | (2,190) | | | 373 | | | (6,942) | | | 2,143 | |
| | | | | | | | |
| Change in deferred gain on retroactive reinsurance under the LPT/ADC Agreement | | (1,192) | | | (6,259) | | | 11,108 | | | (10,722) | |
| | | | | | | | |
| | | | | | | | |
Non-GAAP operating loss (5) | | $ | (11,747) | | | $ | (21,060) | | | $ | (15,173) | | | $ | (11,362) | |
| | | | | | | | |
| | | | | | | | |
| Weighted average number of common shares - basic | | 101,454,767 | | | 87,161,499 | | | 101,586,759 | | | 86,935,823 | |
| Adjusted weighted average number of common shares and assumed conversions - diluted | | 101,454,767 | | | 87,161,499 | | | 101,586,759 | | | 86,935,823 | |
| Reconciliation of diluted (loss) earnings per share (attributable) available to Maiden common shareholders to non-GAAP diluted operating loss per share attributable to Maiden common shareholders: | | | | |
| Diluted loss per share attributable to common shareholders | | $ | (0.03) | | | $ | (0.09) | | | $ | (0.18) | | | $ | 0.22 | |
| Add (subtract): | | | | | | | | |
| Net realized and unrealized investment (gains) losses | | (0.01) | | | 0.02 | | | (0.02) | | | (0.03) | |
| | | | | | | | |
| Foreign exchange and other (gains) losses | | (0.05) | | | (0.10) | | | 0.01 | | | (0.22) | |
| Interest in (income) loss of equity method investments | | (0.02) | | | — | | | (0.07) | | | 0.02 | |
| | | | | | | | |
| Change in deferred gain on retroactive reinsurance under the LPT/ADC Agreement | | (0.01) | | | (0.07) | | | 0.11 | | | (0.12) | |
| | | | | | | | |
| | | | | | | | |
Non-GAAP diluted operating loss per share attributable to common shareholders | | $ | (0.12) | | | $ | (0.24) | | | $ | (0.15) | | | $ | (0.13) | |
| | | | | | | | |
| Non-GAAP Underwriting Results and Non-GAAP Net Loss and LAE | | | | | | |
| Gross premiums written | | $ | 8,660 | | | $ | 5,380 | | | $ | 16,371 | | | $ | (1,451) | |
| Net premiums written | | $ | 8,625 | | | $ | 5,222 | | | $ | 16,260 | | | $ | (1,915) | |
| Net premiums earned | | $ | 12,479 | | | $ | 12,251 | | | $ | 32,520 | | | $ | 23,816 | |
| Other insurance (expense) revenue, net | | (16) | | | 368 | | | 3 | | | 888 | |
Non-GAAP net loss and LAE(9) | | (16,348) | | | (23,685) | | | (25,395) | | | (32,739) | |
| Commission and other acquisition expenses | | (5,340) | | | (5,398) | | | (14,520) | | | (12,811) | |
General and administrative expenses(3) | | (2,877) | | | (2,422) | | | (9,925) | | | (9,288) | |
Non-GAAP underwriting loss(9) | | $ | (12,102) | | | $ | (18,886) | | | $ | (17,317) | | | $ | (30,134) | |
| | | | | | | | |
| Net loss and LAE | | $ | 15,156 | | | $ | 17,426 | | | $ | 36,503 | | | $ | 22,017 | |
| Less: (favorable) adverse prior year loss development covered under the LPT/ADC Agreement | | (1,192) | | | (6,259) | | | 11,108 | | | (10,722) | |
Non-GAAP net loss and LAE(9) | | $ | 16,348 | | | $ | 23,685 | | | $ | 25,395 | | | $ | 32,739 | |
MAIDEN HOLDINGS, LTD.
NON-GAAP FINANCIAL MEASURES (Unaudited)
(In thousands of U.S. dollars, except share and per share data)
| | | | | | | | | | | |
| September 30, 2023 | | December 31, 2022 |
| Investable assets: | | | |
| Total investments | $ | 549,375 | | | $ | 587,060 | |
| Cash and cash equivalents | 17,930 | | | 30,986 | |
| Restricted cash and cash equivalents | 11,600 | | | 15,638 | |
| Loan to related party | 167,975 | | | 167,975 | |
| Funds withheld receivable | 229,568 | | | 441,412 | |
Total investable assets(7) | $ | 976,448 | | | $ | 1,243,071 | |
| | | |
| Capital: | | | |
| | | |
| | | |
Total shareholders' equity | $ | 263,237 | | | $ | 284,579 | |
2016 Senior Notes | 110,000 | | | 110,000 | |
2013 Senior Notes | 152,361 | | | 152,500 | |
Total capital resources(8) | $ | 525,598 | | | $ | 547,079 | |
| | | |
Reconciliation of total shareholders' equity to adjusted shareholders' equity: | | | |
Total Shareholders’ Equity | $ | 263,237 | | | $ | 284,579 | |
| | | |
| Unamortized deferred gain on LPT/ADC Agreement | 56,516 | | | 45,408 | |
Adjusted shareholders' equity(2) | $ | 319,753 | | | $ | 329,987 | |
| | | |
Reconciliation of book value per common share to adjusted book value per common share: | | | |
Book value per common share | $ | 2.60 | | | $ | 2.80 | |
| | | |
| Unamortized deferred gain on LPT/ADC Agreement | 0.56 | | | 0.45 | |
Adjusted book value per common share(2) | $ | 3.16 | | | $ | 3.25 | |
| | | | | | | | |
| (1) Book value per common share is calculated using shareholders’ equity divided by the number of common shares outstanding. Management uses growth in this metric as a prime measure of the value we are generating for our common shareholders, because management believes that growth in this metric ultimately results in growth in the Company’s common share price. This metric is impacted by the Company’s net income and external factors, such as interest rates, which can drive changes in unrealized gains or losses on our investment portfolio, as well as share repurchases. |
| | | |
| (2) Adjusted Total Shareholders' Equity and Adjusted Book Value per Common Share: Management has adjusted GAAP shareholders' equity by adding the unamortized deferred gain on retroactive reinsurance arising from the LPT/ADC Agreement. As a result, by virtue of this adjustment, management has also computed the Adjusted Book Value per Common Share. The deferred gain on retroactive reinsurance represents amounts estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement. We believe reflecting this economic benefit is helpful to understand future trends in our operations, which will improve the Company's shareholders' equity over the settlement period. |
| | |
| (3) Underwriting related general and administrative expenses is a non-GAAP measure and includes expenses which are segregated for analytical purposes as a component of underwriting income (loss). |
| | |
| (4) Underwriting income or loss is a non-GAAP measure and is calculated as net premiums earned plus other insurance revenue less net loss and LAE, commission and other acquisition expenses and general and administrative expenses directly related to underwriting activities. For purposes of these non-GAAP operating measures, the fee-generating business, which is included in our Diversified Reinsurance segment, is considered part of the underwriting operations of the Company. Management believes that this measure is important in evaluating the underwriting performance of the Company and its segments. This measure is also a useful tool to measure the profitability of the Company separately from the investment results and is also a widely used performance indicator in the insurance industry. |
| | |
| (5) Non-GAAP operating earnings (loss) and non-GAAP basic and diluted operating earnings (loss) per common share are non-GAAP financial measure defined by the Company as net income (loss) excluding realized investment gains and losses, foreign exchange and other gains and losses, interest in income (loss) of equity method investment, and (favorable) adverse prior year loss development subject to LPT/ADC Agreement and should not be considered as an alternative to net income (loss). The Company's management believes that the use of non-GAAP operating earnings (loss) and non-GAAP diluted operating earnings (loss) per common share enables investors and other users of the Company’s financial information to analyze its performance in a manner similar to how management analyzes performance. Management also believes that these measures generally follow industry practice therefore allowing the users of financial information to compare the Company’s performance with its industry peer group, and that the equity analysts and certain rating agencies which follow the Company, and the insurance industry as a whole, generally exclude these items from their analyses for the same reasons. Non-GAAP operating earnings should not be viewed as a substitute for U.S. GAAP net income. |
| | |
| (6) Non-GAAP operating return on average adjusted shareholders' equity is a non-GAAP financial measure. Management uses non-GAAP operating return on average adjusted shareholders' equity as a measure of profitability that focuses on the return to common shareholders. It is calculated using non-GAAP operating earnings divided by average adjusted shareholders' equity adjusted for the deferred gain on LPT/ADC Agreement. |
| | |
| (7) Investable assets are the total of the Company's investments, cash and cash equivalents, loan to a related party and funds withheld receivable. |
| | |
| (8) Total capital resources are the sum of the Company's principal amount of debt and shareholders' equity. |
| | |
| (9) Non-GAAP net loss and LAE and Non-GAAP underwriting income (loss): Management has further adjusted the net loss and LAE and underwriting income (loss) (as defined above) by recognizing into income the (favorable) adverse prior year loss development subject to LPT/ADC Agreement relating to losses subject to that agreement. The deferred gain represents amounts estimated to be fully recoverable from Cavello and management believes adjusting for this shows the ultimate economic benefit of the LPT/ADC Agreement on Maiden's underwriting income (loss). Management believes reflecting the economic benefit of this retroactive reinsurance agreement is helpful for understanding future trends in our operations. |
| | | | | | |
| | | | | | |
Exhibit 99.2
PRESS RELEASE
Maiden Holdings, Ltd. Releases
Third Quarter 2023 Financial Results
PEMBROKE, Bermuda, November 8, 2023 (BUSINESS WIRE) -- Maiden Holdings, Ltd. (NASDAQ:MHLD) ("Maiden") has released its third quarter 2023 financial results via its investor relations website. Concurrent with releasing its results, Maiden also published an investor update presentation. Both documents are posted at https://www.maiden.bm/investor_relations.
About Maiden Holdings, Ltd.
Maiden Holdings, Ltd. is a Bermuda-based holding company formed in 2007. Maiden creates shareholder value by actively managing and allocating our assets and capital, including through ownership and management of businesses and assets mostly in the insurance and related financial services industries where we can leverage our deep knowledge of those markets. Maiden also provides a full range of legacy services to small insurance companies, particularly those in run-off or with blocks of reserves that are no longer core, working with clients to develop and implement finality solutions including acquiring entire companies that enable our clients to meet their capital and risk management objectives.
CONTACT:
FGS Global
Maiden@fgsglobal.com
